Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ChangWon C Lee

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Mayo Clinic Proceedings|October 5, 2020
Clinical Development Times for Biosimilars in the United StatesChangWon C Lee, Aaron S Kesselheim, Ameet Sarpatwari
Clinical Pharmacology and Therapeutics|July 13, 2020
Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018Benjamin N Rome, ChangWon C Lee, Aaron S Kesselheim
Clinical Pharmacology and Therapeutics|June 19, 2021
Cost to Medicare of Delayed Adalimumab Biosimilar AvailabilityChangWon C Lee, Mehdi Najafzadeh, Aaron S Kesselheim, et al.
JAMA|August 25, 2018
Medicare Spending on Brand-name Combination Medications vs Their Generic ConstituentsChana A Sacks, ChangWon C Lee, Aaron S Kesselheim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017Benjamin N Rome, ChangWon C Lee, Joshua J Gagne, et al.
JCO Oncology Practice|June 22, 2022
Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and AustraliaThomas J Hwang, Aaron S Kesselheim, Ariadna Tibau, et al.
Health Affairs (Project Hope)|November 19, 2020
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19Aaron S Kesselheim, Jonathan J Darrow, Martin Kulldorff, et al.
JAMA Oncology|July 1, 2021
Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and EuropeKerstin N Vokinger, Thomas J Hwang, Paola Daniore, et al.
Clinical Pediatrics|November 22, 2018
Associations Between Patient-Reported Outcome Measures of Asthma Control and Psychosocial SymptomsChangWon C Lee, Faye F Holder-Niles, Linda Haynes, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Functional and metagenomic level diversities of human gut symbiont-derived glycolipidsJi-Sun Yoo, Byoungsook Goh, Kyoo Heo, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Mayo Clinic Proceedings|October 5, 2020
Clinical Development Times for Biosimilars in the United StatesChangWon C Lee, Aaron S Kesselheim, Ameet Sarpatwari
Clinical Pharmacology and Therapeutics|July 13, 2020
Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018Benjamin N Rome, ChangWon C Lee, Aaron S Kesselheim
Clinical Pharmacology and Therapeutics|June 19, 2021
Cost to Medicare of Delayed Adalimumab Biosimilar AvailabilityChangWon C Lee, Mehdi Najafzadeh, Aaron S Kesselheim, et al.
JAMA|August 25, 2018
Medicare Spending on Brand-name Combination Medications vs Their Generic ConstituentsChana A Sacks, ChangWon C Lee, Aaron S Kesselheim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017Benjamin N Rome, ChangWon C Lee, Joshua J Gagne, et al.
JCO Oncology Practice|June 22, 2022
Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and AustraliaThomas J Hwang, Aaron S Kesselheim, Ariadna Tibau, et al.
Health Affairs (Project Hope)|November 19, 2020
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19Aaron S Kesselheim, Jonathan J Darrow, Martin Kulldorff, et al.
JAMA Oncology|July 1, 2021
Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and EuropeKerstin N Vokinger, Thomas J Hwang, Paola Daniore, et al.
Clinical Pediatrics|November 22, 2018
Associations Between Patient-Reported Outcome Measures of Asthma Control and Psychosocial SymptomsChangWon C Lee, Faye F Holder-Niles, Linda Haynes, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Functional and metagenomic level diversities of human gut symbiont-derived glycolipidsJi-Sun Yoo, Byoungsook Goh, Kyoo Heo, et al.
Pageof 2